HOKKO CHEMICAL INDUSTRY CO.,LTD. [4992.T]
TOKYO, Apr 21 (Pulse News Wire) – Hokko Chemical Industry CO.,LTD. (4992.T) resolved today to implement a new equity-based compensation plan for its directors and executive officers, excluding foreign non-residents.
The plan was approved by shareholders during the 76th Ordinary General Meeting held on January 13, 2026. Details of the plan were finalized at today’s board meeting. Under the new scheme, shares will be entrusted to Resona Bank through a trust agreement set to be concluded on May 08, 2026. The trust will benefit eligible directors and executives who meet the stipulated criteria outlined in the share grant regulations. A third party without vested interests in the company will manage the trust.
Key aspects of the trust include: - Trustee: Resona Bank, which will enter into a specific comprehensive trust agreement with Nippon Custodian Bank, acting as the sub-trustee. - Type of Trust: Non-monetary trust involving monetary assets (beneficiary trust). - Duration: From May 08, 2026 until the termination of the program, with no fixed end date. Regarding the initial setup of the trust, Hokko Chemical plans to acquire a total of 160,000 ordinary shares worth ¥287 million. The acquisition will take place on May 08, 2026 via the acceptance of the company's own stock disposal.
This move underscores the company's commitment to aligning executive remuneration with performance metrics.
🟡 Confidence: Standard AI-translated content.